Results 271 to 280 of about 260,234 (339)

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García   +17 more
wiley   +1 more source

Maternal mortality in Brazil: quality of medical certification of deaths [PDF]

open access: gold, 1999
Arnaldo Augusto Franco de Siqueira   +5 more
openalex  

A heart failure network model to improve outcome and trans‐sectoral guideline‐directed medical treatment utilization

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Heart failure (HF) is a major cause of hospitalization, mortality and healthcare costs. Reducing its socioeconomic burden is a key global public health priority. HF networks are recommended to improve screening and management of HF patients.
Christina Paitazoglou   +13 more
wiley   +1 more source

Disability [PDF]

open access: yes, 2010
Allmark, Peter   +2 more
core  

Lung ultrasound and mortality in a cardiogenic shock population: A prospective registry‐based analysis

open access: yesEuropean Journal of Heart Failure, EarlyView.
Lung ultrasound (LUS) and mortality in cardiogenic shock (CS) patients. Abstract Aims Lung ultrasound (LUS) is a widely used technique to assess de‐aeration in critically ill patients with respiratory failure. There is paucity of data on LUS in cardiogenic shock (CS).
Guido Tavazzi   +19 more
wiley   +1 more source

Medication adherence in patients with acutely decompensated heart failure: A cross‐sectional study in the emergency department (ADHF‐ED)

open access: yesEuropean Journal of Heart Failure, EarlyView.
The ADHF‐ED trial. ADHF, acutely decompensated heart failure; CHF, chronic heart failure; ED, emergency department; EF, ejection fraction; MRA, mineralocorticoid receptor antagonist; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Created with the support of AI (ChatGPT).
Michael Kunz   +9 more
wiley   +1 more source

Rationale and design of the TRIC‐I‐HF‐DZHK24 (TRICuspid Intervention in Heart Failure) trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
Study overview of the TRIC‐I‐HF‐DZHK24 trial. HF, heart failure; HFH, heart failure hospitalization; QoL, quality of life; RHC, right heart catheterization; TR, tricuspid regurgitation; TTVI, transcatheter tricuspid valve intervention. Abstract Aims Tricuspid regurgitation (TR) is a detrimental disease frequently diagnosed in patients with right‐sided ...
Thomas J. Stocker   +110 more
wiley   +1 more source

Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
EMPower the heArt of patients with TermInal Cancer using Cardiac medicines (EMPATICC). eGFR, estomated glomerular filtration rate; EP, endpoint; FCM, ferric carboxymaltose; LVEF, left ventricular ejection fraction; N‐terminal pro‐B‐type natriuretic peptide; PGA, patient global assessment; PoC, proof of concept; QoL, quality of life; UICC, Union for ...
Markus S. Anker   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy